Novel technologies for the discovery and quantitation of biomarkers of toxicity

被引:28
作者
Collings, Fitz B. [1 ]
Vaidya, Vishal S. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div,Harvard Inst Med, Boston, MA 02115 USA
关键词
D O I
10.1016/j.tox.2007.11.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Reliable biomarkers of toxicity are necessary both for the safe conduct of pre-clinical and clinical trials, and are increasingly needed for accurate clinical evaluation of treatment regimens with the potential to cause tissue injury. Recent advances in technology have added several new tools to the biomarker screening toolkit and improved the throughput of existing quantitative assays. Genomics, proteomics, and metabolomics have provided a wealth of data in the search for predictive, specific biomarkers. Multiplexed ELISA-based assay systems, silicon nanowire arrays, and patterned paper present unique abilities for fast, efficient sample analysis over a broad dynamic range. Powerful integrative systems biology software and growing open-source data repositories offer new ways to share, reduce, and analyze data from multiple sources. Novel technologies reviewed here have the potential to significantly reduce assay time and cost and improve the sensitivity of screening methods for candidate biomarkers of toxicity. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 36 条
  • [1] [Anonymous], 2004, INN STAGN CHALL OPP
  • [2] Cutting-edge technology - I. Global gene expression profiling using DNA microarrays
    Arcellana-Panlilio, M
    Robbins, SM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 282 (03): : G397 - G402
  • [3] The PhenoGen Informatics website: tools for analyses of complex traits
    Bhave, Sanjiv V.
    Hornbaker, Cheryl
    Phang, Tzu L.
    Saba, Laura
    Lapadat, Razvan
    Kechris, Katherina
    Gaydos, Jeanette
    McGoldrick, Daniel
    Dolbey, Andrew
    Leach, Sonia
    Soriano, Brian
    Ellington, Allison
    Ellington, Eric
    Jones, Kendra
    Mangion, Jonathan
    Belknap, John K.
    Williams, Robert W.
    Hunter, Lawrence E.
    Hoffman, Paula L.
    Tabakoff, Boris
    [J]. BMC GENETICS, 2007, 8 (1)
  • [4] High-resolution serum proteomic features for ovarian cancer detection
    Conrads, TP
    Fusaro, VA
    Ross, S
    Johann, D
    Rajapakse, V
    Hitt, BA
    Steinberg, SM
    Kohn, EC
    Fishman, DA
    Whiteley, G
    Barrett, JC
    Liotta, LA
    Petricoin, EF
    Veenstra, TD
    [J]. ENDOCRINE-RELATED CANCER, 2004, 11 (02) : 163 - 178
  • [5] Proteomics: Recent applications and new technologies
    Elrick, Mollisa M.
    Walgren, Jennie L.
    Mitchell, Michael D.
    Thompson, David C.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (05) : 432 - 441
  • [6] DNA microarrays: translation of the genome from laboratory to clinic
    Geschwind, DH
    [J]. LANCET NEUROLOGY, 2003, 2 (05) : 275 - 282
  • [7] PrestOMIC, an open source application for dissemination of proteomic datasets by individual laboratories
    Howes, Charles G.
    Foster, Leonard J.
    [J]. PROTEOME SCIENCE, 2007, 5 (1)
  • [8] IDENTIFYING DIFFERENCES IN MESSENGER-RNA EXPRESSION BY REPRESENTATIONAL DIFFERENCE ANALYSIS OF CDNA
    HUBANK, M
    SCHATZ, DG
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (25) : 5640 - 5648
  • [9] Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury
    Ichimura, T
    Bonventre, JV
    Bailly, V
    Wei, H
    Hession, CA
    Cate, RL
    Sanicola, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) : 4135 - 4142
  • [10] A tiling resolution DNA microarray with complete coverage of the human genome
    Ishkanian, AS
    Malloff, CA
    Watson, SK
    deLeeuw, RJ
    Chi, B
    Coe, BP
    Snijders, A
    Albertson, DG
    Pinkel, D
    Marra, MA
    Ling, V
    MacAulay, C
    Lam, WL
    [J]. NATURE GENETICS, 2004, 36 (03) : 299 - 303